Cargando…
Reply to: Challenging the paradigm
Inhaled corticosteroids should be targeted to those with documented airway eosinophilia, not prescribed indiscriminately to all who wheeze. Blind steroid treatment without regard to underlying pathophysiology is not 21st century standard of care. https://bit.ly/34lyaJG
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908864/ https://www.ncbi.nlm.nih.gov/pubmed/35284016 http://dx.doi.org/10.1183/20734735.0174-2021 |
_version_ | 1784665967965503488 |
---|---|
author | Bush, Andrew Pavord, Ian D. |
author_facet | Bush, Andrew Pavord, Ian D. |
author_sort | Bush, Andrew |
collection | PubMed |
description | Inhaled corticosteroids should be targeted to those with documented airway eosinophilia, not prescribed indiscriminately to all who wheeze. Blind steroid treatment without regard to underlying pathophysiology is not 21st century standard of care. https://bit.ly/34lyaJG |
format | Online Article Text |
id | pubmed-8908864 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | European Respiratory Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-89088642022-03-11 Reply to: Challenging the paradigm Bush, Andrew Pavord, Ian D. Breathe (Sheff) Correspondence Inhaled corticosteroids should be targeted to those with documented airway eosinophilia, not prescribed indiscriminately to all who wheeze. Blind steroid treatment without regard to underlying pathophysiology is not 21st century standard of care. https://bit.ly/34lyaJG European Respiratory Society 2022-03 2022-03-08 /pmc/articles/PMC8908864/ /pubmed/35284016 http://dx.doi.org/10.1183/20734735.0174-2021 Text en Copyright ©ERS 2022 https://creativecommons.org/licenses/by-nc/4.0/Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. |
spellingShingle | Correspondence Bush, Andrew Pavord, Ian D. Reply to: Challenging the paradigm |
title | Reply to: Challenging the paradigm |
title_full | Reply to: Challenging the paradigm |
title_fullStr | Reply to: Challenging the paradigm |
title_full_unstemmed | Reply to: Challenging the paradigm |
title_short | Reply to: Challenging the paradigm |
title_sort | reply to: challenging the paradigm |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908864/ https://www.ncbi.nlm.nih.gov/pubmed/35284016 http://dx.doi.org/10.1183/20734735.0174-2021 |
work_keys_str_mv | AT bushandrew replytochallengingtheparadigm AT pavordiand replytochallengingtheparadigm |